Video

The Future Direction of Biosimilars

Transcript:

Related Videos
Sam Brondfield, MD, MA
Related Content
Kassem Faraj, MD, of Michigan Medicine
July 22nd 2024

340B Drug Pricing Program Ostensibly Improves Cancer Care but Carries Unforeseen Consequences

Sorting Through Sexism, Guilt, and Motherhood in Medicine
January 27th 2022

Sorting Through Sexism, Guilt, and Motherhood in Medicine

Tang Renhong, PhD
June 26th 2024

Cetuximab Biosimilar Receives NMPA Approval For RAS/BRAF Wild-Type CRC

Gilbert on Gaining New Ground at Vanderbilt
January 3rd 2022

Gilbert on Gaining New Ground at Vanderbilt

Denosumab Biosimilar Candidate HLX14 for Osteoporosis | Image Credit: © Shutter2U - stock.adobe.com
May 24th 2024

EMA Validates Filings for Denosumab Biosimilar Candidate HLX14 for Osteoporosis

Claire D’Abreu-Hayling, chief scientific officer, Sandoz
May 22nd 2024

European Commission Approves Two Denosumab Biosimilars